Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
CA Stock MarketDetailed Quotes
Quantum BioPharma Ltd (QNTM)
- 9.940
- -0.060-0.60%
15min DelayMarket Closed Jan 15 11:22 ET
38.20MMarket Cap-0.75P/E (TTM)
9.940High9.570Low733Volume9.570Open10.000Prev Close7.07KTurnover52.00052wk High0.02%Turnover Ratio3.84MShares4.20052wk Low-13.295EPS TTM35.76MFloat Cap52.000Historical HighLossP/E (Static)3.60MShs Float3.900Historical Low-18.871EPS LYR3.70%Range %--Dividend TTM3.18P/B1Lot Size--Div Yield TTM
Quantum BioPharma Ltd (QNTM) Income Statement
Quarterly+Annual
YOY
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating revenue | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Cost of revenue | ||||||||||
| Gross profit | ||||||||||
| Operating expense | 14.36%4.66M | 41.57%4.91M | 50.26%3.39M | -18.84%15.88M | 202.91%6.09M | 45.48%4.07M | -36.45%3.47M | -75.77%2.25M | -28.65%19.57M | -69.83%2.01M |
| Selling and administrative expenses | 25.26%4.02M | 73.36%4.22M | -18.51%1.61M | -29.49%9.31M | -11.66%1.69M | 19.42%3.21M | -11.22%2.44M | -66.32%1.97M | -17.37%13.2M | -31.70%1.92M |
| -General and administrative expense | 25.26%4.02M | 73.36%4.22M | -18.51%1.61M | -29.49%9.31M | -11.66%1.69M | 19.42%3.21M | -11.22%2.44M | -66.32%1.97M | -17.37%13.2M | -31.70%1.92M |
| Research and development costs | -33.51%495.22K | -38.84%549.2K | 928.55%1.65M | 57.63%6.08M | 14,386.34%4.28M | 2,358.00%744.8K | -44.24%897.99K | -93.07%160.26K | -44.16%3.86M | -101.11%-29.96K |
| Depreciation amortization depletion | 20.30%145.34K | 3.34%141.38K | 7.95%129.69K | -80.43%490.57K | -7.70%112.8K | -17.71%120.81K | -87.64%136.81K | -89.37%120.14K | -44.76%2.51M | -89.44%122.22K |
| -Depreciation and amortization | 20.30%145.34K | 3.34%141.38K | 7.95%129.69K | -80.43%490.57K | -7.70%112.8K | -17.71%120.81K | -87.64%136.81K | -89.37%120.14K | -44.76%2.51M | -89.44%122.22K |
| Operating profit | -14.36%-4.66M | -41.57%-4.91M | -50.26%-3.39M | 18.84%-15.88M | -202.91%-6.09M | -45.48%-4.07M | 36.45%-3.47M | 75.77%-2.25M | 28.65%-19.57M | 69.83%-2.01M |
| Net non-operating interest income (expenses) | -103.03%-4.66K | -250.77%-144.84K | -277.00%-283.4K | -33.17%525.31K | -24.80%115.64K | -12.01%153.5K | -48.40%96.07K | -41.07%160.11K | 146.48%786.06K | -48.72%153.78K |
| Non-operating interest income | -38.72%100.42K | -13.11%90.73K | -61.04%67.22K | -27.15%572.89K | -14.12%132.08K | -5.86%163.87K | -43.91%104.42K | -36.65%172.52K | 113.84%786.36K | -48.74%153.79K |
| Non-operating interest expense | 913.16%105.08K | 2,718.87%235.57K | 2,724.36%350.62K | 15,812.04%47.58K | 136,858.33%16.44K | --10.37K | --8.36K | 1,761.17%12.41K | -99.39%299 | -91.11%12 |
| Other net income (expenses) | 11.45%-84.75K | -21,187.11%-4.71M | -302,296.54%-5.07M | -19.92%443.19K | 152.25%514.89K | -106.41%-95.71K | 110.41%22.33K | 100.18%1.68K | 35.97%553.46K | -3.47%204.12K |
| Gain on sale of security | 5.39%-102.2K | -29,364.89%-6.53M | -19,797.03%-3.77M | -272.22%-293.22K | -151.48%-226.67K | 79.14%-108.03K | -96.80%22.33K | 104.25%19.15K | -40.80%170.25K | 107.74%440.31K |
| Special income (charges) | -8.69%11.25K | ---110.27K | 1,159.34%185.13K | 116.08%732.42K | 412.28%737.57K | --12.32K | --0 | 96.36%-17.48K | ---4.56M | ---236.19K |
| -Less:Impairment of capital assets | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --4.56M | ---- |
| -Less:Other special charges | 8.69%-11.25K | --110.27K | -1,159.34%-185.13K | ---732.42K | ---737.57K | ---12.32K | ---- | --17.48K | ---- | ---- |
| -Less:Write off | ---- | ---- | ---- | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
| Other non-operating income (expenses) | --6.2K | --1.94M | ---1.48M | -99.92%3.99K | ---- | ---- | ---- | ---- | 4,034.69%4.94M | --0 |
| Income before tax | -18.24%-4.75M | -191.31%-9.77M | -317.89%-8.74M | 18.18%-14.92M | -230.37%-5.46M | -254.96%-4.02M | 38.94%-3.35M | 79.00%-2.09M | 31.73%-18.23M | 73.14%-1.65M |
| Income tax | ||||||||||
| Earnings from equity interest net of tax | ||||||||||
| Net income | -18.24%-4.75M | -191.31%-9.77M | -317.89%-8.74M | 18.18%-14.92M | -230.37%-5.46M | -254.96%-4.02M | 38.94%-3.35M | 79.00%-2.09M | 22.77%-18.23M | 73.14%-1.65M |
| Net income continuous operations | -18.24%-4.75M | -191.31%-9.77M | -317.89%-8.74M | 18.18%-14.92M | -230.37%-5.46M | -254.96%-4.02M | 38.94%-3.35M | 79.00%-2.09M | 31.73%-18.23M | 73.14%-1.65M |
| Net income discontinuous operations | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --0 | ---- |
| Noncontrolling interests | 403.70%571.43K | -113.34%-513.26K | 13.24%-163.16K | -117.05%-712.81K | 62.65%-96.02K | -163.67%-188.16K | -240.58K | -188.05K | -328.41K | -257.05K |
| Net income attributable to the company | -38.98%-5.32M | -197.34%-9.25M | -350.61%-8.58M | 20.66%-14.2M | -284.38%-5.36M | -261.11%-3.83M | 43.32%-3.11M | 80.89%-1.9M | 24.17%-17.9M | 77.32%-1.39M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | -38.98%-5.32M | -197.34%-9.25M | -350.61%-8.58M | 20.66%-14.2M | -284.38%-5.36M | -261.11%-3.83M | 43.32%-3.11M | 80.89%-1.9M | 24.17%-17.9M | 77.32%-1.39M |
| Diluted earnings per share | 71.40%-1.25 | 37.88%-3.23 | -2.92%-3.53 | 56.16%-13.12 | 18.97%-2.331 | -148.62%-4.37 | 42.86%-5.2 | 79.70%-3.43 | 24.44%-29.93 | 72.23%-2.8769 |
| Basic earnings per share | 71.40%-1.25 | 37.88%-3.23 | -2.92%-3.53 | 56.16%-13.12 | 18.97%-2.331 | -148.62%-4.37 | 42.86%-5.2 | 79.70%-3.43 | 24.44%-29.93 | 72.23%-2.8769 |
| Dividend per share | ||||||||||
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Market Insights
HK Tech and Internet Stocks HK Tech and Internet Stocks
Stocks of companies primarily involved in technology and internet sectors in the HK stock market. Stocks of companies primarily involved in technology and internet sectors in the HK stock market.
View More
Nancy Pelosi Portfolio Nancy Pelosi Portfolio
Former U.S. House Speaker Pelosi, renowned as the "Stock Market Queen" in politics, concentrates her investment portfolio on tech giants in AI and semiconductors. Her core strategy involves purchasing call options for leveraged trading to maximize potential returns. Former U.S. House Speaker Pelosi, renowned as the "Stock Market Queen" in politics, concentrates her investment portfolio on tech giants in AI and semiconductors. Her core strategy involves purchasing call options for leveraged trading to maximize potential returns.
Hot Topics Hot Topics
Will the 'tariff stick' strike again? Will the market remain 'reactive'?
China and the United States have successively adjusted multiple tariff and non-tariff measures, beginning to implement the consensus outcome
牛牛課堂
Oct 13, 2025 18:05
[Opportunity Express] The US-China rivalry escalates! The rare earth industry becomes a "game-changer." How should investors respond?
Food流油
Apr 14, 2025 15:43
"Leaving the Group - Raising Taxes - Tweeting: The 'Money Making Strategy' of the Most Wild Gemini in Contemporary Times"